Literature DB >> 21900523

Detection of an influenza B virus strain with reduced susceptibility to neuraminidase inhibitor drugs.

Nathalie Bastien, Jonathan B Gubbay, David Richardson, Katrina Sleeman, Larisa Gubareva, Yan Li.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21900523      PMCID： PMC3209080          DOI： 10.1128/JCM.05069-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  7 in total

1.  Mutation in the influenza virus neuraminidase gene resulting in decreased sensitivity to the neuraminidase inhibitor 4-guanidino-Neu5Ac2en leads to instability of the enzyme.

Authors:  J L McKimm-Breschkin; M McDonald; T J Blick; P M Colman
Journal:  Virology       Date:  1996-11-01       Impact factor: 3.616

2.  A single sequence change destabilizes the influenza virus neuraminidase tetramer.

Authors:  J M Colacino; N Y Chirgadze; E Garman; K G Murti; R J Loncharich; A J Baxter; K A Staschke; W G Laver
Journal:  Virology       Date:  1997-09-15       Impact factor: 3.616

3.  Sequence and structure alignment of paramyxovirus hemagglutinin-neuraminidase with influenza virus neuraminidase.

Authors:  P M Colman; P A Hoyne; M C Lawrence
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

4.  Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-guanidino-Neu5Ac2en.

Authors:  L V Gubareva; M J Robinson; R C Bethell; R G Webster
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

5.  Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.

Authors:  Tiffany G Sheu; Varough M Deyde; Margaret Okomo-Adhiambo; Rebecca J Garten; Xiyan Xu; Rick A Bright; Eboneé N Butler; Teresa R Wallis; Alexander I Klimov; Larisa V Gubareva
Journal:  Antimicrob Agents Chemother       Date:  2008-07-14       Impact factor: 5.191

Review 6.  Influenza virus neuraminidase inhibitors.

Authors:  L V Gubareva; L Kaiser; F G Hayden
Journal:  Lancet       Date:  2000-03-04       Impact factor: 79.321

7.  The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid.

Authors:  W P Burmeister; R W Ruigrok; S Cusack
Journal:  EMBO J       Date:  1992-01       Impact factor: 11.598
  7 in total
  7 in total

Review 1.  Neuraminidase inhibitors for influenza B virus infection: efficacy and resistance.

Authors:  Andrew J Burnham; Tatiana Baranovich; Elena A Govorkova
Journal:  Antiviral Res       Date:  2013-09-04       Impact factor: 5.970

Review 2.  The continual threat of influenza virus infections at the human-animal interface: What is new from a one health perspective?

Authors:  Emily S Bailey; Jessica Y Choi; Jane K Fieldhouse; Laura K Borkenhagen; Juliana Zemke; Dingmei Zhang; Gregory C Gray
Journal:  Evol Med Public Health       Date:  2018-09-07

3.  Analysis of influenza B virus lineages and the HA1 domain of its hemagglutinin gene in Guangzhou, southern China, during 2016.

Authors:  Feng Ye; Xiao-Juan Chen; Wen-da Guan; Si-Hua Pan; Zi-Feng Yang; Rong-Chang Chen
Journal:  Virol J       Date:  2018-11-14       Impact factor: 4.099

4.  Detection and Characterization of Influenza B Virus With Reduced Neuraminidase Susceptibility in a Stem Cell Transplant Recipient.

Authors:  Rosy Priya L Kodiyanplakkal; Jennifer M Laplante; Lars F Westblade; Koen van Besien; Mirella Salvatore; Kirsten St George
Journal:  Open Forum Infect Dis       Date:  2019-11-18       Impact factor: 3.835

5.  Molecular Characterization of Seasonal Influenza A and B from Hospitalized Patients in Thailand in 2018-2019.

Authors:  Kobporn Boonnak; Chayasin Mansanguan; Dennis Schuerch; Usa Boonyuen; Hatairat Lerdsamran; Kultida Jiamsomboon; Fanny Sae Wang; Arun Huntrup; Jarunee Prasertsopon; Nathamon Kosoltanapiwat; Pilaipan Puthavathana
Journal:  Viruses       Date:  2021-05-25       Impact factor: 5.048

6.  Genetic analysis of influenza B viruses isolated in Uganda during the 2009-2010 seasons.

Authors:  Denis K Byarugaba; Bernard Erima; Monica Millard; Hannah Kibuuka; Lukwago L; Josephine Bwogi; Derrick Mimbe; Edison A Mworozi; Bridget Sharp; Scott Krauss; Richard J Webby; Robert G Webster; Samuel K Martin; Fred Wabwire-Mangen; Mariette F Ducatez
Journal:  Virol J       Date:  2013-01-05       Impact factor: 4.099

7.  A New Master Donor Virus for the Development of Live-Attenuated Influenza B Virus Vaccines.

Authors:  Chantelle L White; Kevin Chiem; Daniel R Perez; Jefferson Santos; Stivalis Cardenas Garcia; Aitor Nogales; Luis Martínez-Sobrido
Journal:  Viruses       Date:  2021-06-30       Impact factor: 5.048
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.